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AngII-induced inﬂammation were partly related to TLR4. Cotreatment of CFs with
pioglitazone and AngII revealed no effect on AngII TypeI receptor (AT1), but
downregulated AT1-dependent ERK1/2 phosphorylation. Furthermore, pioglitazone
inhibited AngII-induced MCP-1 and TNF-a production and overexpression of TLR4,
Myd88 and NF-kB; and increased nuclear-PPARg production in CFs.
Conclusions: These results suggest that TLR4 is involved in the AngII-induced in-
ﬂammatory responses in CFs, and pioglitzone provides its anti-inﬂammatory and
antiﬁbrotic effect which is partly depend on interfering with the TLR4-dependent
signaling pathway (AT1/ERK1/2/TLR4/Myd88/NF-kB) to prevent the hypertension
induced ventricle remodeling.
GW25-e0069
Ambulatory Blood Pressure Monitoring of Healthy Chinese Children Aged
5-12 Years
Yan Zhihui1, Li Yuyang1,2, Li Aiqing1, Li Jing1, Zhao Ziyan1
1Anti-Senility Research Center of Shandong, Institute of Materia Medica, Shandong
Academy of Medical Sciences, 2The Second Hospital of Shandong University
Objectives: We studied the characteristics of ambulatory blood pressure (ABP) and
their inﬂuence factors in healthy Chinese children.
Methods: Casual blood pressure (BP), ABP, body height, weight, body mass index
(BMI), personal and familial medical histories were recorded in 338 Chinese children
(aged 5-12 years). Data were treated by ABP database system and analyzed by SPSS
20.0 including correlations, regressions and conventional statistical methods.
Results: Means of 24-Hour SBP/DBP/PP (systolic BP/diastolic BP/pulse pressure)
were 112.710.2/66.35.7/46.67.3 and 110.98.1/66.55.1/44.66.0 mmHg in
normal weight 118 boys and 139 girls, and were 118.311.3/67.96.5/50.78.7 and
113.621.4/65.712.2/48.111.5 mmHg in overweight 46 boys and 35 girls,
respectively. BMI, weight and gender were primary inﬂuencing factors on ABP-
derived parameters. Overweight children had higher means (P<.01 or <.05) of sys-
tolic BP (SBP) and pulse pressure (PP), and higher hypertensive prevalence (35% vs.
15% for boys and 40% vs. 18% for girls) than normal weight children. Boys had
higher (P <.01) means of PP (24-Hour /Daytime) than girls in normal weight children.
Age related negatively with DBP and body height correlated with heart rate. Circadian
variations of ABP (dipper pattern) were seen in most of children (76%). Familial
histories of hypertension showed no inﬂuence on ABP.
Conclusions: BMI, weight and gender were the main inﬂuencing factors on ABP
in Chinese children and our data provides basic information of ABP in Chinese
children.
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Objectives: The aim of this study was to investigate the effect of the human adipo-
nectin (Hapm1) gene-modiﬁed stromal vascular fraction (SVF) cells (Hapm1-SVF)
transplantation on the cardiac function and histological changes of heart tissue in rats
with myocardial infarction.
Methods: Rats were divided into four groups (n¼8) : sham-operated (sham), un-
treated myocardial infarction (MI), SVF treated (SVF), and HapM1-SVF (SVF car-
rying human adiponectin gene and labeled with EGFP) treated (HapM1-SVF) groups.
The MI model was established by ligation of the left anterior descending coronary
arteries. SVF were injected into the infracted border zone of MI rats. EF and FS were
detected by echocardiography 4 weeks after the cells transplantation. LVSP and
LVDP were measured by PowerLab biological signal analytical system. Vascular
density was determined by immunohistochemical staining.
Results: It was shown that LVSP and LVDP were signiﬁcantly increased in MI rats
treated with SVF cells or HapM1 gene-modiﬁed SVF cells as compared with untreated
MI rats, but still not reach the normal level [LVSP: sham (99.357.45) VS MI
(72.835.37) VS SVF (77.857.82) VS Hapm1-SVF (84.238.65) mmHg, P<0.05].
EF and FS of rats in HapM1-SVF or SVF groups were signiﬁcantly higher than that of
MI rats, but still not reach the normal level (EF: sham (81.854.63%) VS MI
(43.213.10%) VS SVF (64.934.13%) VS Hapm1-SVF (74.563.60%), P<0.05).
Meanwhile, the density of vessels in HapM1-SVF group was higher than that in SVF
or MI group, but still lower than that in sham group.
Conclusions: In summary, transplantation of SVF cells carrying hapM1 gene may
stimulate recovery of cardiac function after myocardial infarction in rats.
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Objectives: Klotho (KL) is a recently discovered aging-suppressing gene. Insertional
mutation of KL gene resulted in a premature aging syndrome. Overexpression of KLC14 JACC Vol 64/16/Suppl C j Octobgene extended the lifespan by 20% and rescued other aging disorders. Hypertension
and kidney damage are common aging-related diseases. The purpose of this study is to
assess if KL deﬁciency affects blood pressure (BP) and renal damage as well as the
underlying mechanism.
Methods: One group of heterozygous mutant KL (KL (+/-) ) mice and one group of
wild type (WT) mice were used to measure BP continuously when they were from the
age of 8 months to 13 months. Each strain of mice was further divided into 2 sub-
groups when the mice were at the age of 15 months, which received eplerenone
treatment (6 mg/kg/day, IP) or an equal dose vehicle, respectively. BP was measured
and urine was collected during treatment. At the end of the treatment for 3 weeks, the
animals were sacriﬁced and blood was collected. Plasma aldosterone level was
detected with an aldosterone ELISA kit. Kidney sections were used for periodic acid
Schiff staining, Masson’s trichrome staining and immunohistochemical staining (CD4,
CD8, and CD68). Adrenal sections were used for immunohistochemical staining
(klotho, CYP11B2). Plasma urea and creatinine level were detected with quanti-
chromTM assay kits. Urinary albumin concentration was measured with a micro-
albuminuria ELISA kit. Western blotting was done to detect the expression of MR,
SGK1, NCC, and ATP synthase b, TNF-a, MCP-1, IL-6 and osteopontin in kidney.
Results: The results demonstrated that the systolic BP was signiﬁcantly and persis-
tently elevated accompanied by aldosterone level increase and CYP11B2 (key enzyme
of aldosterone synthesis) upregulation in KL (+/-) mice. Chronic treatment with
eplerenone (aldosterone receptor blocker) decreased hypertension to the control level
and prevented the upregulation of SGK1, NCC and ATP synthase b level in kidneys
of KL (+/-) mice, suggesting that KL deﬁciency causes hypertension due to plasma
aldosterone increase and the subsequent renal sodium retention through SGK1-NCC
signaling. Moreover, signiﬁcant renal structure damage (glomerulus collapse, tubule
ﬁbrosis) and function decline (plasma creatinine, urea and urine albumin increase)
were observed in KL (+/-) mice. Further analysis indicated that several proin-
ﬂammatory cytokines (TNFa, MCP-1, IL-6 and osteopontin) were upregulated and
leucocyte (T cell and macrophage) inﬁltration were increased in kidneys of KL (+/-)
mice. Eplerenone rescued KL deﬁciency-induced kidney damage and abolished the
activated inﬂammatory process.
Conclusions: KL is essential to the maintenance of normal BP. KL deﬁciency caused
hypertension and kidney damage via upregulating aldosterone level and consequently
increasing inﬂammation and SGK1-NCC signaling in kidneys.
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Cellular repressor of E1A-stimulated genes protects against angiotensin
II-induced hypertension and vascular remodeling via p38MAPK-mediated
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Objectives: Cellular repressor of E1A-stimulated genes (CREG) has been proposed to be
a new cardiovascular homeostasis regulator. We hypothesized that CREG is a negative
regulator of angiotensin (Ang) II-mediated hypertension and vascular remodeling.
Methods: Ten-week-old male heterozygous CREG-deﬁcient (CREG+/-) mice and
their littermate wild-type (WT) mice were implanted with osmotic minipumps con-
taining saline, Ang II (1.5 mg/kg$d), or Ang II and recombinant human CREG
(rhCREG; 15-300 mg/kg$d) protein for 14 days. Ang II-infused CREG+/- mice were
then cotreated with p38 MAPK inhibitor, SB203580 (10 mg/kg$d), beginning 2 days
before minipump implantation. Systolic blood pressure (SBP); extent of vascular
remodeling; RNA and protein level of CREG, collagen type I/III, angiotensin-con-
verting enzyme-2 (ACE2), angiotensin receptor type 1 (AT1R), Ets-1 and MAPK
were evaluated. Primary vascular smooth muscle cell (VSMC) culture was performed
to assess the mechanism of Ang II-induced CREG down-regulation, as well as CREG-
mediated modulation of renin-angiotensin system.
Results: CREG levels are high in vascular media under basal conditions but rapidly
decrease in response to Ang II. Ets-1 transcription factor expression is upregulated in
Ang II-stimulated VSMCs. Chromatin immunoprecipitation analysis showed the
interaction of endogenous and exogenous Ets-1 or glutathione S-transferase-tagged
Ets-1, bearing only the DNA-binding domain with the authentic CREG promoter.
Moreover, Ets-1 siRNA knockdown signiﬁcantly reduced Ang II-induced repression
of CREG expression, indicating Ets-1 mediates Ang II-induced down-regulation of
CREG expression. Ang II infusion for 14 days resulted that levels of SBP, intima
medial thickness and vascular remodeling of the aorta and mesenteric artery were
signiﬁcantly greater in CREG+/- mice compared with the WT controls. Vascular gene
expression level of CREG was lower in Ang II-treated CREG+/- mice than in WT
mice, suggesting that CREG deﬁciency aggravates Ang II-induced hypertension and
vascular remodeling. However, daily treatment of Ang II-infused WT mice with
rhCREG protein improved the above phenotypes. Ang II-induced vascular remodeling
was inhibited by rhCREG protein in association with reduced plasma Ang II and
increased plasma Ang 1-7 levels. Furthermore, rhCREG treatment inhibited Ang II-
mediated up-regulation of AT1R expression and down-regulation of ACE2 expression
by blocking p38MAPK activation. Finally, pharmacological blockade of p38MAPK
with SB203580 abolished CREG deﬁciency mediated the aggravation of Ang II-
induced hypertension and vascular remodeling.
Conclusions: Ets-1 mediates Ang II-induced down-regulation of CREG expression.
Elevated Ang II induced hypertension and vascular remodeling, which were exac-
erbated by CREG deﬁciency, whereas rhCREG protein attenuated Ang II-induced
hypertension and vascular remodeling through modulation of balance betweener 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
ACE/Ang II/AT1R axis and ACE2/Ang 1-7/Mas1 axis via p38MAPK signaling
pathway. Hence, CREG is an important negative regulator of Ang II-induced hy-
pertension and suppresses adverse vascular remodeling, leading to a new thera-
peutic approach to the treatment of hypertensive vascular remodeling.
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Objectives: The proliferation of cardiac ﬁbroblast cells (CFs) contribute to the
development of cardiac remodeling which will ultimately lead to cardiac remolding. In
this study, we have investigated the effect and molecular mechanisms of hesperetin
(HES) on the Angiotensin II (Ang II) -induced proliferation of primary cultured rat
CFs.
Methods: When CFs received different factor intervention for 24h; the toxicity of
HES on CFs was determined by the trypan blue exclusion test; cell proliferation was
determined using a non-radioactive colorimetric Cell Counting Kit CCK-8 assay,
DNA syntheses of the CFs were assessed by measuring the incorporation of BrdU;
Cell cycle progression was determined using ﬂuorescence-activated cell sorting
(FACS); the mRNA expression associated with the cell cycle was testing by RT-PCR;
Western blot domenstrated the signaling pathway.
Results: Our data demonstrated that HES signiﬁcantly inhibited the proliferation of
CFs induced by Ang II in a dose-dependent manner without cell cytotoxicity (both of
DNA and proteins synthesis levels). In accordance with these ﬁndings, HES blocked
progression through G0/G1 to S phase of the cell cycle. We also demonstrated that
HES inhibit the cell cycle was associated with the inhibition of the mRNA expression
of cyclin D1, CDK6, as well as an increase of the mRNA and protein expression of
p21/WAF in Ang II-stimulated CFs. Further studies showed that the beneﬁcial effect
of HES on blocking the proliferation of CFs is related to suppression of the AKT/
GSK3b signaling pathway, but has little effect on the extracellular signal-regulated
kinase (ERK) 1/2, p38 and JNK signaling pathways.
Conclusions: These results demonstrate that HES suppresses Ang II-induced CFs
proliferation through the AKT/GSK3b signaling pathway and suggests that it may be
a feasible therapy for cardiac remodeling diseases.
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Objective: To identify the drug-drug interaction of clopidogrel and atorvastatin based
on bioinformatic analysis.
Methods: this study conducted cell-based microarray and bioinformatic analysis of
the impact of atorvastatin and clopidogrel carboxylic acid exposure on endothelial cell
response. human umbilical vein endothelial cell line EA.hy926 were treated with
10mM of atorvastatin or 10mM of clopidogrel carboxylic acid for 24 h, then the cell-
based microarray were performed. Gene set enrichment analysis (GSEA), Database
for Annotation, Visualization, and Integrated Discovery (DAVID) and the cMap
database were used to analysis the gene expression data. The target differenced genes
of atorvastatin and clopidogrel carboxylic acid were validated by real-time polymerase
and Weston-blot.
Results: A total of 649 genes were found to show at least 2-fold changes in
EA.hy926 cells after treatment with atorvastatin, including 295 up-regulated and 354
down-regulated genes. The bioinformatics analysis using GSEA and DAVID
revealed that Kruppel-like factors (KLFs) and cell-cycle related genes are the genes
most signiﬁcantly affected by atorvastatin treatment. The cMap analysis suggested
that atorvastatin acted as an HDAC inhibitor and similar with resveratrol. A total of
235 genes were found to show at least 1.5-fold changes in EA.hy926 cells after
treatment with clopidogrel carboxylic acid, including 176 up-regulated and 59 down-
regulated genes. The bioinformatics analysis showed that genes belonged to Toll-like
receptor, Nod-like receptor signaling pathway and IL-6 signaling pathway were up-
regulated, the regulation of transcription, RNA formation and signal transduction
were also affected by clopidogrel carboxylic acid. The cMap analysis suggested that
clopidogrel carboxylic acid was similar with 15d-PGJ2. The up-regulation of KLFs
and the down-regulation of cell-cycle related genes, including CCNA2, CCNE2,
CCNB1, CCNB2, FOS, IL-8 et al were validated by real-time polymerase chain
reaction (RT-PCR) andWeston-blot. The results were consistent with the microarray
data.
Conclusion: Atorvastatin played the anti-atherosclerotic role through through multi-
ple mechanisms. The mechanism may be similar to the HDAC inhibitors and
resveratrol; clopidogrel carboxylic acid increases inﬂammatory gene pathway, and
was similar to the mechanism of 15d-PGJ2. From gene expression proﬁles analysis,
there was no signiﬁcant antagonism between atorvastatin and clopidogrel carboxylic
acid.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e5370
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Objectives: Observation the roles of P2X7R in atherosclerosis. Investigate the
mechanism of NLRP3 inﬂammasome activated in atherosclerosis.
Methods: We also observed the expression and distribution of P2X7R and NLRP3 in
the atherosclerosis plaque of coronary artery from autopsy by immunoﬂuorescence.
The expressions of P2X7R, NLRP3, IL-1bof THP-1 macrophages were observed by
Real-time PCR and western blot. The level of IL-1b in the media supernatant and mice
plasma was assayed by ELISA. The co-immunoprecipitation was used to observe the
interaction between PKR phosphorylation and NLRP3. Finally, expressions of P2X7R
and PKR phosphorylation were observed in apoE-/- mice aortic sinus by immuno-
histochemistry and immunoﬂuorescence.
Results: The expression of P2X7R and NLRP3 in the human plaque is extremely
intensity co-location with macrophages by Immunoﬂuorescence. In vitro, We found
the concentration of IL-1b in culture medium from THP-1 treated by 100mg/ml for 24
hours is higher than control group. (321.9377.7 pg/ml, vs 8.802.05pg/ml,
P<0.01). And the expressions of proIL-1b, P2X7R and NLRP3 in cytoplasm of THP-
1 cells incubated by oxLDL were up-regulation. And lots of mature IL-1b were
produced. Although NLRP3 was knocked down by siRNA, the expression of proIL-
1b kept the high level. However, the level of mature IL-1b in the NLRP3 siRNA
group prominent lower than the negative control. In vitro, Incubation with P2X7R
siRNA, the expressions of proIL-1b in THP-1 by oxLDL were not decreased.
However, the IL-1b activation was inhibited. The concentration of IL-1b in culture
medium, which in the P2X7R siRNA group, was signiﬁcantly lower, compared to the
negative control (67.3518.72 pg/ml vs 340.78101.88pg/ml,P<0.01). Co-immu-
noprecipitation indicates when P2X7R inhibited by siRNA, PKR phosphorylation was
lower signiﬁcantly, and NLRP3 interacting with PKR phosphorylation was sup-
pressed. And then, the activated caspase-1 was also reduced. In vivo, for 12 weeks
high cholesterol diet, In the lesions of apoE-/- mice aortic sinus., P2X7R expression
was intensive. The ELISA indicated IL-1b in plasma of apoE-/- mice fed by high
cholesterol diet for 4weeks, 8weeks, 12weeks prominent higher than control
(51.5613.28 pg/ml,140.2736.11 pg/ml,171.3445.21 pg/ml,vs 8.872.27 pg/
ml,P<0.01). Compared to apoE-/- and apoE-/-NC (negative control), the atheroscle-
rosis in apoE-/-P2X7R-/- was attenuated. The IL-1b level in plasma of apoE-/-P2X7R-/-
mice was lower than control and negative control (81.5725.79pg/ml vs
157.3340.01 pg/ml,P<0.05;81.5725.79pg/ml vs 160.3235.59 pg/ml P<0.05).
PKR phosphorylation levels was elevating in the locaiton of P2X7R positive with
atherosclerosis developement.
Conclusions: oxLDL could promote expressions of proIL-1b, NLRP3 and P2X7R in
macrophages.P2X7R regulates the assemble and activation of NLRP3 inﬂammasome
by controlling the level of PKR phosphorylation, but P2X7R could not regulate the
expression of NLRP3 mRNA and protein directly.P2X7R plays important roles in the
apoE-/- mice atherosclerosis development.
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Objectives: MicroRNAs play key roles in atherosclerosis-related diseases. However,
the effects of miR-146a, miR-125a, and miR-34b/c polymorphisms on coronary artery
disease (CAD) and acute myocardial infarction (AMI) susceptibility have not been
explored.
Methods: A cross-sectional study examined patients with CAD. The rs2910164 (miR-
146a), rs12976445 (miR-125a) and rs4938723 (miR-34b/c) polymorphisms were
analyzed using SNPshot minisequencing. The association between the risk genotype
and the proportion of patients with 3-vessel disease, 1-vessel disease, left main trunk
disease, and coronary artery bypass graft surgery was tested, as was its association
with the modiﬁed Gensini coronary scoring indexes. All patients were experienced
follow-up for 102 weeks. The miR-146aC>G polymorphism was obviously associ-
ated with CAD and AMI prevalence.
Results: A multivariate logistic regression analysis indicated that the genotype dis-
tribution of the rs2910164 polymorphism was associated signiﬁcantly with the
angiographical characteristics of coronary atherosclerosis risk. The variant genotypes
GG of rs2910164 (miR-146a) were associated with a signiﬁcantly increased risk of
CHD (adjusted OR¼2.481, 95% CI¼1.151-5.346) and coronary stenosis (adjusted
OR¼2.280, 95% CI¼1.130-4.599), compared with genotype CC. The miR-125a and
miR-34b/c polymorphisms were not associated with risk of CAD. Among CAD cases,
3-vessel disease demonstrated a strong, direct association with the variant genotypesasic and Translational Medicine C15
